NSE: BALAMINES | BSE: 530999

Mid-range Performer

Download real time

1274.00 9.50 (0.75%)

High vol. this week

NSE 16 Jan, 2026 3:31 PM (IST)

4,127.9

Market Cap

High in industry

Beta 1Year

Very High Volatility

Balaji Amines Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for BALAMINES, BSE:530999 Balaji Amines Ltd.

Balaji Amines Ltd.

09 Feb 2022

1274.00

0.75%

Balaji Amines Ltd | Q3FY22 Result Update

Buy: Balaji Amines Ltd.

Target

Edelweiss

Better utilisation and mix to drive medium term earnings

Balaji Amines Ltd. is trading above its 50 day SMA of 1167.3

Balaji Amines Ltd.

29 Oct 2021

1274.00

0.75%

Balaji Amines Ltd - Result Update Q2FY22

Buy: Balaji Amines Ltd.

Target

Edelweiss

Balaji Amines Ltd (BAL) witnessed strong top-line growth across standalone Amines business and subsidiary Balaji Specialty Chemicals (BSC).

Balaji Amines Ltd. is trading above its 50 day SMA of 1167.3

Balaji Amines Ltd.

28 Jun 2021

1274.00

0.75%

Balaji Amines Ltd

Buy: Balaji Amines Ltd.

Target

CD Equisearch

oxygen and logistical issues. Total Q4 sales volume stood at 24,878 mt, a 12.3% decline on a quarter-on-quarter quarter basis. Of this specialty chemicals...

Balaji Amines Ltd. is trading above its 50 day SMA of 1167.3

Balaji Amines Ltd.

27 May 2021

1274.00

0.75%

Balaji Amines Ltd | Q4FY21 Result Update

Buy: Balaji Amines Ltd.

Target

Edelweiss

Stellar quarter; new capacities to drive growth in FY22

Balaji Amines has lost -28.50% in the last 6 Months

Balaji Amines Ltd.

11 Feb 2021

1274.00

0.75%

Balaji Amines Ltd | Q3FY21 Result Update

Buy: Balaji Amines Ltd.

Target

Edelweiss

Balaji Amines (BAL) posted record high results in Q3FY21 consolidated revenue grew 72% YoY/39% QoQ to INR392cr (v/s est. 37% growth).

Balaji Amines Ltd. is trading above its 50 day SMA of 1167.3

Balaji Amines Ltd.

04 Nov 2020

1274.00

0.75%

Balaji Amines | Q2FY21 Result Update

Buy: Balaji Amines Ltd.

Target

Edelweiss

Balaji Amines Ltd's (BAL) Q2FY21 consolidated revenue was at a record INR 282 crore, up 24% YoY/27% QoQ, and was 13% ahead of our estimates.

Balaji Amines Ltd. has an average target of 1334.00 from 1 broker.

Balaji Amines Ltd.

31 Aug 2020

1274.00

0.75%

Balaji Amines Ltd.

Buy: Balaji Amines Ltd.

Target

CD Equisearch

Sub optimal capacity utilization in April and May operating at 70% and 80% respectively, due to Covid hampered volumes in the first quarter this fiscal which plummeted almost 18% sequentially on an absolute basis,...

Balaji Amines has lost -28.50% in the last 6 Months

Balaji Amines Ltd.

16 Aug 2020, 12:00AM

1274.00

0.75%

Balaji Amines Ltd - Result Update Q1FY21

Buy: Balaji Amines Ltd.

Target

Edelweiss

Balaji Amines' (BAL) margin expanded in Q1FY21 on the back of a favourable product mix and benign raw material environment.

Balaji Amines has lost -28.50% in the last 6 Months

Balaji Amines Ltd.

28 Feb 2020

1274.00

0.75%

Balaji Amines Ltd.

Buy: Balaji Amines Ltd.

CD Equisearch

BAL started manufacturing acetonitrile from November with an installed capacity of 9000 tons. The domestic demand for acetonitrile is around 12000 tons annually. BAL is currently manufacturing ~3000 tons of...